1. 1. Hudyvok Ya.S., Sheremetha L.M., Aravitska M.H. et al. Vplyv preparati z hepatoprotectornou dieu na protsesy obminu rechovyn v umovah eksperymentalnyh toksychnyh hepatytiv [The influence of drugs with hepatoprotective effect on metabolic processes in experimental toxic hepatitis]. Pharmacologichni doslidshennya biologichno activnyh rechovyn. 2014; 4: 118-121. (In Ukrainian).
2. 2. Akriviadis E., Botla R., Briggs W. et al. Pentoxifylline improves short-term survival in severe acute alcoholic hepatitis: a double-blind, placebocontrolled trial. Gastroenterology. 2000; 119:1637.
3. 3. Datsko V.А., Fedoniuk L.Ya., Ivankiv Ya.I., et al. Experimental cirrhosis: liver morphology and function. Wiad. Lek. 2020;73(5):947-952.
4. 4. Gebhardt R., Beckers G., Gaunits F. et.al. Treatment of cirrhotic rats with L-ornithin-aspartate enhances urea synthesis and lowers serum ammonia levels. J. Phamacol. Exp. Ther. 1997; 283: 1-6.
5. 5. Korolenko T.A., Kondakova A.E., Tytova V.H. Subkletochnoe rasspredilenie kislyh hidrolaz petcheni krys pri toksicheskom hepatite [Subcellular distribution of acidic hydrolases in the liver of rats with toxic hepatitis]. Buleten eksperimentalnoi biologii i mediciny. 1975;7:34-36. (In Russian).